Similar articles

• Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems.

  McGeer PL, McGeer EG, Hattori T. McGeer PL, et al. Adv Biochem Psychopharmacol. 1977;16:397-402. Adv Biochem Psychopharmacol. 1977. PMID: 329651 No abstract available.
• Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.

  Bartholini G, Scatton B, Worms P, Zivkovic B, Lloyd KG. Bartholini G, et al. Adv Biochem Psychopharmacol. 1981;30:119-28. Adv Biochem Psychopharmacol. 1981. PMID: 6120626 No abstract available.
• The effect of gamma-acetylenic GABA, an enzyme-activated irreversible inhibitor of GABA-transaminase, on dopamine pathways of the extrapyramidal and limbic systems.

  Palfreyman MG, Huot S, Lippert B, Schechter PJ. Palfreyman MG, et al. Eur J Pharmacol. 1978 Aug 15;50(4):325-36. doi: 10.1016/0014-2999(78)90138-3. Eur J Pharmacol. 1978. PMID: 699960
• Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions.

  Di Chiara G, Morelli M, Acquas E, Carboni E. Di Chiara G, et al. Arzneimittelforschung. 1992 Feb;42(2A):231-7. Arzneimittelforschung. 1992. PMID: 1586394 Review.
• Use of the neurotoxic agents kainic acid and tetanus toxin in the extrapyramidal system.

  McGeer PL, McGeer EG. McGeer PL, et al. Adv Cytopharmacol. 1979;3:437-46. Adv Cytopharmacol. 1979. PMID: 157675 Review. No abstract available.